Eyes on New Product Development.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Works matching IS 10807683 AND DT 2024 AND VI 40 AND IP 9
Results: 10
1
2
Regulatory Requirements of Biosimilars: Drug Development in Ophthalmology, Part 1.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
3
Long-Term Stability, Sterility, And Cost-Effectiveness of 0.05% Chlorhexidine Gluconate as Antisepsis for Intravitreal Injection.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 581, doi. 10.1089/jop.2024.0071
- By:
- Publication type:
- Article
4
Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 588, doi. 10.1089/jop.2024.0074
- By:
- Publication type:
- Article
5
Two Decades of Research in Drug Delivery Systems for the Treatment of Diseases of the Posterior Segment of the Eye.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
6
Changes in Human Meibum Lipid Composition Related to the Presence and Severity of Meibomian Gland Dysfunction.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 562, doi. 10.1089/jop.2024.0063
- By:
- Publication type:
- Article
7
Comparative Ocular Pharmacokinetics of Dexamethasone Implants in Rabbits.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 608, doi. 10.1089/jop.2024.0052
- By:
- Publication type:
- Article
8
Basic Fibroblast Growth Factor Supports the Function of Limbal Niche Cells via the Wnt/β-Catenin Pathway.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 571, doi. 10.1089/jop.2024.0042
- By:
- Publication type:
- Article
9
Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 553, doi. 10.1089/jop.2024.0029
- By:
- Publication type:
- Article
10
Neuritin 1 Drives Therapeutic Preservation of Retinal Ganglion Cells in an Ex Vivo Human Glaucoma Model.
- Published in:
- Journal of Ocular Pharmacology & Therapeutics, 2024, v. 40, n. 9, p. 596, doi. 10.1089/jop.2024.0041
- By:
- Publication type:
- Article